These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22734426)

  • 21. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil: in vitro evaluation of drug permeation by infrared spectroscopy.
    Mura S; Manconi M; Fadda AM; Sala MC; Perricci J; Pini E; Sinico C
    Pharm Dev Technol; 2013; 18(6):1339-45. PubMed ID: 22563642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and irritancy of enhancers on the in-vitro and in-vivo percutaneous absorption of curcumin.
    Fang JY; Hung CF; Chiu HC; Wang JJ; Chan TF
    J Pharm Pharmacol; 2003 May; 55(5):593-601. PubMed ID: 12831501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved Dermal and Transdermal Delivery of Curcumin with SmartFilms and Nanocrystals.
    Eckert RW; Wiemann S; Keck CM
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33804137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transdermal patches for site-specific delivery of anastrozole: In vitro and local tissue disposition evaluation.
    Xi H; Yang Y; Zhao D; Fang L; Sun L; Mu L; Liu J; Zhao N; Zhao Y; Zheng N; He Z
    Int J Pharm; 2010 May; 391(1-2):73-8. PubMed ID: 20170718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
    Yang Z; Teng Y; Wang H; Hou H
    Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of chemical enhancers on percutaneous absorption of daphnetin in isopropyl myristate vehicle across rat skin in vitro.
    Wen Z; Fang L; He Z
    Drug Deliv; 2009 May; 16(4):214-23. PubMed ID: 19280376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
    Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
    Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of penetration enhancers on the transdermal delivery of bupranolol through rat skin.
    Babu RJ; Pandit JK
    Drug Deliv; 2005; 12(3):165-9. PubMed ID: 16025846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and irritancy of enhancers on the in-vitro and in-vivo percutaneous absorption of curcumin.
    Fang JY; Hung CF; Chiu HC; Wang JJ; Chan TF
    J Pharm Pharmacol; 2003 Aug; 55(8):1175. PubMed ID: 12956910
    [No Abstract]   [Full Text] [Related]  

  • 30. [Influence of penetration enhancers on in vitro transdermal permeation of L-tethrahydropalmatine].
    Qian L; Ma Z; Zhang W; Wang Q
    Zhongguo Zhong Yao Za Zhi; 2011 Jul; 36(13):1729-32. PubMed ID: 22032134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Curcumin nanoemulsion for transdermal application: formulation and evaluation.
    Rachmawati H; Budiputra DK; Mauludin R
    Drug Dev Ind Pharm; 2015 Apr; 41(4):560-6. PubMed ID: 24502271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of paeonol-loaded transethosomes as transdermal delivery carriers.
    Chen ZX; Li B; Liu T; Wang X; Zhu Y; Wang L; Wang XH; Niu X; Xiao Y; Sun Q
    Eur J Pharm Sci; 2017 Mar; 99():240-245. PubMed ID: 28039091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomaterials as novel penetration enhancers for transdermal and dermal drug delivery systems.
    Chen Y; Wang M; Fang L
    Drug Deliv; 2013; 20(5):199-209. PubMed ID: 23763451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems.
    Babu RJ; Pandit JK
    Int J Pharm; 2005 Jan; 288(2):325-34. PubMed ID: 15620873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selection of high efficient transdermal lipid vesicle for curcumin skin delivery.
    Zhao YZ; Lu CT; Zhang Y; Xiao J; Zhao YP; Tian JL; Xu YY; Feng ZG; Xu CY
    Int J Pharm; 2013 Sep; 454(1):302-9. PubMed ID: 23830940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Optimization and characterization of curcumin-piperine dual drug loaded self-microemulsifying drug delivery system by simplex lattice design].
    Li QP; Dai JD; Zhai WW; Jiang QL
    Zhongguo Zhong Yao Za Zhi; 2014 Oct; 39(20):3936-44. PubMed ID: 25751942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lidocaine self-sacrificially improves the skin permeation of the acidic and poorly water-soluble drug etodolac via its transformation into an ionic liquid.
    Miwa Y; Hamamoto H; Ishida T
    Eur J Pharm Biopharm; 2016 May; 102():92-100. PubMed ID: 26945484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Essential oils and their constituents as skin penetration enhancer for transdermal drug delivery: a review.
    Herman A; Herman AP
    J Pharm Pharmacol; 2015 Apr; 67(4):473-85. PubMed ID: 25557808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomembrane model interaction and percutaneous absorption of papaverine through rat skin: effects of cyclodextrins as penetration enhancers.
    Ventura CA; Fresta M; Paolino D; Pedotti S; Corsaro A; Puglisi G
    J Drug Target; 2001; 9(5):379-93. PubMed ID: 11770707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design of optimized diffusion-controlled transdermal drug delivery systems.
    Nauman EB; Patel K; Karande P
    Drug Dev Ind Pharm; 2011 Jan; 37(1):93-102. PubMed ID: 20608879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.